Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
JSPRW
JSPRW | US
0.02
USD0
0%
JSPRW | US
About JSPRW
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
16/03/2026
Close
0.02
Open
0.02
High
0.02
Low
0.02
Jasper Therapeutics Inc. a clinical-stage biotechnology company develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191 a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City California.
View LessJSPRW | US
Risk
171.8
Sharpe
0
Luna's Score
49/100
Recommendation
Hold
Luna says (JSPRW | US)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
61.2%1 month
171.8%3 months
353.2%6 months
290.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-67.01M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-59.32
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.00
Range1M
0.01
Range3M
0.11
Volumes: Market Activity
Rel. volume
0.10
Price X volume
8.01
